Advanced single-cell sequencing technologies are essential tools for providing insights into cellular processes driving development, regeneration and disease progression, including pediatric cancers. These cutting-edge single-cell technologies also contribute to the ambitious goal of understanding blood cell regeneration in healthy, diseased, and therapeutic contexts. In my current role as project manager, with a strong background in stem cell biology and pediatric cancer research, I help coordinate the teams and projects within both the Belderbos group and the Single Cell Genomics Facility, ensuring efficient research progress and development for both teams. The ultimate goal is to translate our understanding of cellular processes to improve therapies. Specifically, gaining a fundamental understanding of hematopoietic stem cell biology will aid in developing novel therapies to benefit pediatric cancer patients undergoing hematopoietic cell transplantation.
Phone -